- Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung
-
Jung M, Lee CH, Park HS, Lee JH, Kang YA, Kim SK, Chang J, Kim DJ, Rha SY, Kim JH, Cho BC
- KMID: 2158218
- Yonsei Med J.
- 2013 Jul;54(4):854-864.
- doi: 10.3349/ymj.2013.54.4.854
PURPOSE: The main objective of this study was to evaluate the association between polymorphisms of the target genes of pemetrexed and clinical outcomes in non-small cell lung cancer (NSCLC) patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Biomarkers for Colorectal Cancer Treatment
-
Suk KT, Kim HS
- KMID: 1062808
- Korean J Gastroenterol.
- 2009 Feb;53(2):68-75.
Individualized tailored therapy is a currently pursuing direction for improving the outcome of patients with colorectal cancer. Targeted therapy is the potential strategy to reach this goal by evaluating status... -
- CITED
-
- Close
- SHARE
-
- Close
